Related Experiment Videos
[Expression of p29, estrogen receptor related protein in primary breast carcinoma. Methodological, anatomoclinical,
1Departamento de Cirugía, Facultad de Medicina Universidad de La Frontera, Temuco, Chile.
Abstract:
The aim of this work was to assess the immunohistochemical detection of a estrogen receptor related protein (p29) in 48 histological samples of primary mammary carcinoma and its relationship to clinical, morphological and ADN content parameters. p29 protein was positive in 62.5% of samples. Over 50% of samples had a moderate or intense immunohistochemical staining (staining index over 16) and 77% has a heterogeneous expression of p29 protein. Seventy six percent of p29 positive and 53% of p29 negative tumors had a proliferation fraction over 10% (determined by the S fraction with flux cytometry). No relationship between p29 expression and the analyzed anatomoclinical variables was found. These results highlight this immunohistochemical method as an alternative to more complex and difficult biochemical techniques. On the other hand, the good results obtained in formalin fixed tissues allow retrospective studies in mammary carcinoma samples.
Insights
This study evaluated the immunohistochemical detection of estrogen receptor related protein (p29) in breast cancer. While p29 expression showed no link to clinical factors, the method is a viable alternative for retrospective studies.
Area of Science:
- Oncology
- Biochemistry
- Immunohistochemistry
Context:
- Mammary carcinoma research requires reliable protein detection methods.
- Estrogen receptor related protein (p29) role in breast cancer is under investigation.
- Existing biochemical techniques for p29 detection can be complex.
Purpose:
- To assess immunohistochemical detection of p29 in primary mammary carcinoma.
- To explore the relationship between p29 expression and clinical, morphological, and DNA content parameters.
- To evaluate p29 as a potential biomarker in breast cancer.
Summary:
- Immunohistochemical analysis of p29 was performed on 48 primary mammary carcinoma samples.
- p29 protein was detected in 62.5% of samples, with heterogeneous expression common.
- No significant correlation was found between p29 expression and clinical or morphological variables, including proliferation fraction.
Impact:
- Immunohistochemistry offers a practical alternative to complex biochemical assays for p29 detection.
- Formalin-fixed tissues yield good results, enabling retrospective studies in breast cancer.
- This method facilitates further research into p29's role in mammary carcinoma.